Endoscopic Submucosal Dissection Market by Product, Indication, End User

Description

List of Tables

The Endoscopic Submucosal Dissection Market was valued at USD 320.68 million in 2023, expected to reach USD 339.99 million in 2024, and is projected to grow at a CAGR of 6.95%, to USD 513.38 million by 2030.

Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure used to remove tumors from the gastrointestinal tract, primarily targeting early-stage cancers in the stomach, esophagus, and colon. ESD's necessity stems from its ability to preserve healthy tissues while removing lesions, providing a definitive treatment when detected early and potentially reducing the need for more invasive surgeries. Its applications are significant in countries with high incidences of gastric cancers, such as Japan and South Korea, but it is gaining traction in the Western markets due to rising awareness and technological advancements. The end-use scope predominantly includes hospitals and specialized endoscopic centers, where trained physicians can perform the procedure. Market growth is driven by technological advancements in endoscopic equipment, increasing prevalence of gastrointestinal cancers, and rising preference for minimally invasive procedures. Improved healthcare infrastructure, increased healthcare spending, and growing patient awareness also contribute to its expansion. There is a notable opportunity in expanding training programs for surgeons, integrating AI for precise diagnostics, and enhancing cross-disciplinary research for novel ESD techniques. However, limitations such as high costs, a steep learning curve for practitioners, and potential complications, including bleeding and perforations, pose challenges. Furthermore, varying reimbursement scenarios across regions can impact adoption rates. Areas ripe for innovation include the development of advanced imaging techniques to identify early-stage lesions, AI-driven tools for improving the precision and outcomes of ESD procedures, and creating cost-effective and user-friendly devices for emerging markets. The market exhibits a competitive landscape with established players focusing on R&D investments and strategic partnerships to enhance their product offerings. Understanding these dynamics, companies should focus on innovation to reduce costs, improve outcomes, and enhance accessibility to capitalize on the growing demand for minimally invasive cancer treatments.

KEY MARKET STATISTICS
Base Year [2023]	USD 320.68 million
Estimated Year [2024]	USD 339.99 million
Forecast Year [2030]	USD 513.38 million
CAGR (%)	6.95%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endoscopic Submucosal Dissection Market

The Endoscopic Submucosal Dissection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing geriatric population coupled with rising incidences of cancer
- Favorable reimbursement policies for endoscopic procedures
- Growing adoption of minimally invasive surgeries across the globe
Market Restraints
- High capital and maintenance cost of endoscopic submucosal dissection procedures
Market Opportunities
- Increasing number of approvals for endoscopic submucosal dissection techniques
- Technological advancements in endoscopic submucosal dissection techniques and devices
Market Challenges
- Side effects associated with postoperative infection of endoscopic submucosal dissection procedures

Porter's Five Forces: A Strategic Tool for Navigating the Endoscopic Submucosal Dissection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endoscopic Submucosal Dissection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endoscopic Submucosal Dissection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endoscopic Submucosal Dissection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endoscopic Submucosal Dissection Market

A detailed market share analysis in the Endoscopic Submucosal Dissection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endoscopic Submucosal Dissection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endoscopic Submucosal Dissection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endoscopic Submucosal Dissection Market

A strategic analysis of the Endoscopic Submucosal Dissection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Submucosal Dissection Market, highlighting leading vendors and their innovative profiles. These include Advanced Endoscopy Devices, Inc., Ambu A/S, Angelus Medical and Optical, Anrei Medical, Aohua Endoscopy Co., Ltd., Aspen Surgical, Avante Medical Surgical, Beijing ZKSK Technology Co., Ltd., Boston Scientific Corporation, ConMed Corporation, Cook Group Incorporated, Creo Medical, Duomed Group, EndoMed Systems GmbH, Endoss GmbH, Erbe Elektromedizin GmbH, Etsy, Inc., Flexicare Medical Ltd., Fujifilm Holdings Corporation, Guangzhou Happycare Electronics Co., Ltd., Hangzhou AGS MedTech Co., Ltd., HMB Endoscopy Products, Hoya Corporation, Huger Medical Instrument Co., Ltd., Interscope, Inc., Jiangsu Maslech Medical Technology Co., Ltd., Jiangsu Vedkang Medical Science and Technology Co., Ltd., Karl Storz SE & Co. KG, Lenox Instrument Company, Leo Medical Co. Ltd., Medi-Globe GmbH by DCC Healthcare, MedTec Applications, Inc., Medtronic PLC, Micro-Tech Endoscopy, MicroAire Surgical Instruments, LLC, Mizuho America, Inc., MTW-Endoskopie W. Haag KG, Olympus Corporation, Optim LLC, Ovesco Endoscope AG, Port Macquarie Gastroenterology, Pride Medical Instruments Technology Jiangsu Co., Ltd., Richard Wolf Industrial, SonoScape Medical Corp., Steris Corporation, Sumitomo Bakelite Co., Ltd., Taewoong Medical, The Surgical Company, Vector Medical, and Zeon Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Endoscopic Submucosal Dissection Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Cap & Hood, Forceps & Clips, Gastroscopes & Colonoscopes, and Knives. The Knives is further studied across Dual, Flex, Hook, Insulation-tipped, Needle, and Triangle-tipped.
Based on Indication, market is studied across Colon & Rectum Cancer, Esophageal Cancer, and Stomach Cancer.
Based on End User, market is studied across Ambulatory Surgical Centres, Hospitals, and Specialty Clinics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-F611BFBC6402

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing geriatric population coupled with rising incidences of cancer
  - 5.1.1.2. Favorable reimbursement policies for endoscopic procedures
  - 5.1.1.3. Growing adoption of minimally invasive surgeries across the globe
- 5.1.2. Restraints
  - 5.1.2.1. High capital and maintenance cost of endoscopic submucosal dissection procedures
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing number of approvals for endoscopic submucosal dissection techniques
  - 5.1.3.2. Technological advancements in endoscopic submucosal dissection techniques and devices
- 5.1.4. Challenges
  - 5.1.4.1. Side effects associated with postoperative infection of endoscopic submucosal dissection procedures
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Endoscopic Submucosal Dissection Market, by Product

6.1. Introduction
6.2. Cap & Hood
6.3. Forceps & Clips
6.4. Gastroscopes & Colonoscopes
6.5. Knives
- 6.5.1. Dual
- 6.5.2. Flex
- 6.5.3. Hook
- 6.5.4. Insulation-tipped
- 6.5.5. Needle
- 6.5.6. Triangle-tipped

7. Endoscopic Submucosal Dissection Market, by Indication

7.1. Introduction
7.2. Colon & Rectum Cancer
7.3. Esophageal Cancer
7.4. Stomach Cancer

8. Endoscopic Submucosal Dissection Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centres
8.3. Hospitals
8.4. Specialty Clinics

9. Americas Endoscopic Submucosal Dissection Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Endoscopic Submucosal Dissection Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Submucosal Dissection Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field
- 12.3.2. Fujifilm expands endoscopy solutions for gastrointestinal applications
- 12.3.3. Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc.
- 12.3.4. Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
- 12.3.5. Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
- 12.3.6. Medtronic launches AI-driven endoscopy module to detect, treat colorectal cancer
- 12.3.7. Lumendi Receives 510(k) Clearance for Two Endoscopy Devices
- 12.3.8. Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Advanced Endoscopy Devices, Inc.
2. Ambu A/S
3. Angelus Medical and Optical
4. Anrei Medical
5. Aohua Endoscopy Co., Ltd.
6. Aspen Surgical
7. Avante Medical Surgical
8. Beijing ZKSK Technology Co., Ltd.
9. Boston Scientific Corporation
10. ConMed Corporation
11. Cook Group Incorporated
12. Creo Medical
13. Duomed Group
14. EndoMed Systems GmbH
15. Endoss GmbH
16. Erbe Elektromedizin GmbH
17. Etsy, Inc.
18. Flexicare Medical Ltd.
19. Fujifilm Holdings Corporation
20. Guangzhou Happycare Electronics Co., Ltd.
21. Hangzhou AGS MedTech Co., Ltd.
22. HMB Endoscopy Products
23. Hoya Corporation
24. Huger Medical Instrument Co., Ltd.
25. Interscope, Inc.
26. Jiangsu Maslech Medical Technology Co., Ltd.
27. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
28. Karl Storz SE & Co. KG
29. Lenox Instrument Company
30. Leo Medical Co. Ltd.
31. Medi-Globe GmbH by DCC Healthcare
32. MedTec Applications, Inc.
33. Medtronic PLC
34. Micro-Tech Endoscopy
35. MicroAire Surgical Instruments, LLC
36. Mizuho America, Inc.
37. MTW-Endoskopie W. Haag KG
38. Olympus Corporation
39. Optim LLC
40. Ovesco Endoscope AG
41. Port Macquarie Gastroenterology
42. Pride Medical Instruments Technology Jiangsu Co., Ltd.
43. Richard Wolf Industrial
44. SonoScape Medical Corp.
45. Steris Corporation
46. Sumitomo Bakelite Co., Ltd.
47. Taewoong Medical
48. The Surgical Company
49. Vector Medical
50. Zeon Medical Inc.